Rating History for Frequency Therapeutics (FREQ) by Chardan

More Stocks Rated by Chardan | Latest Ratings for FREQ
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/15/2023 David Gataulin Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.75
(0.30)		 -60% Details